Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Derma Sciences unveils two new Medihoney formulations for wound dressings

Derma Sciences : 27 June, 2008  (New Product)
Derma Sciences has unveiled two new formulations of its key product line, Medihoney Wound and Burn Dressings.
The new products consist of 100 percent Active Leptospermum Honey packaged in a tube, and a patented colloidal sheet referred to as a Honeycolloid. These two new formulations will greatly enhance the brand's utilisation in variety of wounds, including lightly draining wounds, wounds that are difficult to dress due to their anatomical location, and wounds on patients that are sensitive to pain at dressing changes.

Chief executive officer of Derma Sciences, Ed Quilty said, 'We are very excited about these two new products hitting the market. Our customers have been requesting a Medihoney version dispensed from a tube. This will help them to reach and dress difficult areas. It also provides a dressing to be used when the wound is not draining. The Honeycolloid is based on one of the patents we licensed from our global commercialisation partner, Comvita New Zealand. This dressing is the most sophisticated in the line, combining ease-of-use attributes with strong clinical benefits'.

'The Leptospermum honey is intrinsically bound within the dressing, allowing the honey to stay at the site of the wound longer even in the presence of exudate. This is a key challenge with honey based dressings used on exudating wounds'.

'Additionally, although decreasing the pH of a wound has been proven to have significant healing benefits, quickly reducing the pH of a wound can cause slight transient stinging in a small percentage of patients. This happens with several popular wound care products including enzymatic debriding agents and honey-based dressings. With the Honeycolloid formulation, even though it is comprised of 80 percent honey, the pH modulation takes a longer amount of time, thus reducing the chance of any transient stinging. For patients with painful leg ulcers, this will be a real benefit'.

'We have already come a very long way in establishing Medihoney as a strong up-and-coming brand in the United States and Canada' Quilty added. “This week's Wound Ostomy and Continence Nursing annual conference held in Orlando was a huge success for Derma Sciences. Awareness of the brand is very strong among clinicians, and we should see a spike in an already impressive rate of clinical evaluations. The addition of these new formulations, especially the patented Honeycolloid dressing, adds to the brand and further distances us from any other potential competitors.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo